AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Rekasi, Z Schally, AV Plonowski, A Czompoly, T Csernus, B Varga, JL
Citation: Z. Rekasi et al., Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormoneand vasoactive intestinal peptide, PROSTATE, 48(3), 2001, pp. 188-199

Authors: Kahan, Z Varga, JL Schally, AV Rekasi, Z Armatis, P Chatzistamou, I Czompoly, T Halmos, G
Citation: Z. Kahan et al., Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice, BREAST CANC, 60(1), 2000, pp. 71-79

Authors: Rekasi, Z Varga, JL Schally, AV Halmos, G Groot, K Czompoly, T
Citation: Z. Rekasi et al., Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro, P NAS US, 97(3), 2000, pp. 1218-1223

Authors: Halmos, G Schally, AV Varga, JL Plonowski, A Rekasi, Z Czompoly, T
Citation: G. Halmos et al., Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone, P NAS US, 97(19), 2000, pp. 10555-10560

Authors: Rekasi, Z Czompoly, T Schally, AV Halmos, G
Citation: Z. Rekasi et al., Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers, P NAS US, 97(19), 2000, pp. 10561-10566

Authors: Rekasi, Z Varga, JL Schally, AV Halmos, G Armatis, P Groot, K Czompoly, T
Citation: Z. Rekasi et al., Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: Evidence from in vitro studies on human prostatic and pancreatic cancer, ENDOCRINOL, 141(6), 2000, pp. 2120-2128
Risultati: 1-6 |